MPO-to-albumin ratio at admission predicts 90-day stroke recurrence

Xiangqi Kong1, Haobo Wang1, Penghong Li1

  • 1Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032,China.

Abstract

Insights

The MPO/Alb ratio, measuring oxidative-inflammatory imbalance, predicts 90-day acute ischemic stroke recurrence. Higher ratios indicate increased risk, aiding early stroke prevention strategies.

Area of Science:

  • Neurology
  • Biochemistry
  • Cardiovascular Medicine

Background:

  • Acute ischemic stroke (AIS) is a leading cause of death and disability globally.
  • Stroke recurrence significantly worsens patient outcomes.
  • Oxidative-inflammatory imbalance, involving myeloperoxidase (MPO) and albumin (Alb), is implicated in AIS recurrence.

Purpose of the Study:

  • To investigate the association between the MPO-to-albumin ratio (MPO/Alb) and 90-day stroke recurrence in AIS patients.
  • To evaluate MPO/Alb as a potential biomarker for predicting AIS recurrence.

Main Methods:

  • Retrospective cohort study of 422 AIS patients.
  • Collection of baseline clinical and laboratory data, including MPO/Alb ratio calculation.
  • Assessment of 90-day stroke recurrence via follow-up, analyzed using multivariable logistic regression, quartile trends, and restricted cubic spline (RCS) modeling.

Main Results:

  • 23 out of 422 patients experienced 90-day recurrence.
  • Patients with recurrence had significantly higher MPO and MPO/Alb levels.
  • Elevated MPO/Alb independently predicted increased recurrence risk (OR=1.21 per unit increase), showing a dose-response relationship and linear association.

Conclusions:

  • The MPO/Alb ratio is an independent predictor of 90-day recurrence in AIS.
  • This simple, inexpensive biomarker may assist in early risk stratification for secondary stroke prevention.
  • Further validation in multicenter prospective studies is warranted.